Orthobiologics for the Management of Early Arthritis in the Middle-Aged Athlete. Review uri icon

Overview

abstract

  • This article is dedicated to the use of orthobiologic therapies in the management of early osteoarthritis in middle-aged athletes. Understanding a patient's presenting symptoms, physical examination, imaging results, and goals is of critical importance in applying orthobiologic therapies. The field of orthobiologics is expanding at a rapid pace, and the clinical studies examining the utility of each treatment lag behind the direct-to-consumer marketing that leads to these products being used. Here we provide a review of the available treatments, emerging treatments, and the current literature supporting or refuting their use. Currently studied orthobiologics include autologous and allogenic cell therapies, autologous blood products, hyaluronic acid, gene therapies, Wnt inhibitors, and a variety of systemic treatments.

publication date

  • May 4, 2022

Research

keywords

  • Osteoarthritis

Identity

Scopus Document Identifier

  • 85129528407

Digital Object Identifier (DOI)

  • 10.1097/JSA.0000000000000337

PubMed ID

  • 35533063

Additional Document Info

volume

  • 30

issue

  • 2